Tango Therapeutics, INC. (TNGX) SEC Filings — 2024
17 SEC filings for Tango Therapeutics, INC. (TNGX) in 2024.
Filings
- Tango Therapeutics, INC. SC 13G Filing — SC 13G · Nov 20, 2024
- Boxer Capital Ups Tango Therapeutics Stake to 14.9% — SC 13D/A · Nov 7, 2024
- Tango Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 6, 2024
- Boxer Capital Ups Tango Therapeutics Stake — SC 13D/A · Oct 28, 2024
- Boxer Asset Management Amends Tango Therapeutics Stake — SC 13D/A · Oct 15, 2024
- Third Rock Ventures Amends Tango Therapeutics Stake — SC 13D/A · Sep 4, 2024
- Tango Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Tango Therapeutics Files 8-K on Shareholder Votes and Financials — 8-K · Jun 6, 2024
- Gilead to Acquire Tango Therapeutics for $1.24B — 8-K · May 23, 2024
- Tango Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Tango Therapeutics Files Definitive Proxy Statement for 2024 Annual Meeting — DEF 14A · Apr 29, 2024
- Tango Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Apr 8, 2024
- Tango Therapeutics Files 8-K for Financials — 8-K · Mar 18, 2024
- Tango Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Tango Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Disclose 9.596% Stake in Tango Therapeutics — SC 13G/A · Feb 9, 2024
- Tango Therapeutics Files 8-K on Financial Results — 8-K · Feb 7, 2024